Huons Co., Ltd. (KOSDAQ:243070)

South Korea · Delayed Price · Currency is KRW

26,700

+300 (1.14%)

Aug 11, 2026, 2:19 PM KST

-8.40% (1Y)

Market Cap	307.61B -9.8%
Revenue (ttm)	616.80B +4.8%
Net Income	30.69B -3.7%
EPS	2,611.50 -0.4%
Shares Out	11.65M
PE Ratio	10.11
Forward PE	n/a
Dividend	920.00 (3.46%)
Ex-Dividend Date	May 26, 2026

Volume	14,184
Open	26,400
Previous Close	26,400
Day's Range	26,300 - 27,200
52-Week Range	22,500 - 41,500
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1965

Employees 912

Stock Exchange KOSDAQ

Ticker Symbol 243070

Full Company Profile

Financial Performance

In 2025, Huons's revenue was 620.77 billion, an increase of 5.17% compared to the previous year's 590.23 billion. Earnings were 42.66 billion, an increase of 44.84%.

Financial Statements